SCS
MRTX

Syquant Capital SAS’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Syquant Capital SAS’s Portfolio MRTX Stock Details MRTX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-153,920
Closed -$9.04M – 13
2023
Q4 		$9.04M Buy
+153,920
New +$9.04M 40.81% 1